InspireMD stock rises after US commercial launch of carotid stent system

Published 09/07/2025, 14:00
© Reuters.

Investing.com -- InspireMD Inc . (NASDAQ:NSPR) stock climbed 4% in pre-market trading following the commercial launch of its CGuard Prime carotid stent system in the United States.

The company announced that the launch comes after receiving premarket application approval from the Food and Drug Administration. The CGuard Prime system is designed to minimize both early and late embolism risk by trapping potential emboli against arterial walls while maintaining external carotid artery perfusion.

InspireMD’s CGuard Prime features a dual layer design that combines an open-cell frame with what the company describes as the smallest mesh pore size available. The system also incorporates MicroNet™ technology, a bio-stable mesh made from a single 20 μm Polyethylene Terephthalate strand, and SmartFit™ technology that eliminates the need for tapered versions.

"Our U.S. commercial launch marks a pivotal milestone in InspireMD’s expansion history, having already secured double-digit market share across more than 30 countries," said Marvin Slosman, Chief Executive Officer of InspireMD.

Dr. D. Chris Metzger, System Vascular Chief at OhioHealth, noted that the CGuard’s design "makes a real difference in addressing the complexities of carotid artery disease, offering enhanced embolic protection without compromising deliverability."

The company has spent the past year preparing for this launch by building a commercial team of industry veterans to execute its U.S. market entry strategy.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.